By: IPP Bureau
Last updated : April 27, 2026 6:45 am
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
L V Prasad Eye Institute (LVPEI) has inaugurated the Eye and Brain Centre at its Kallam Anji Reddy Campus in Hyderabad, with support from D. E. Shaw India, marking a significant step toward advancing integrated care for complex neuro-ophthalmic conditions.
The newly launched centre is an interdisciplinary initiative designed to bring together expertise in neuroscience and ophthalmology, with a focus on training, research, diagnostics, and comprehensive patient care. It will house a state-of-the-art neuro-ophthalmology clinical and diagnostic facility, alongside a neuroscience laboratory equipped for genetic testing.
The centre will also leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders.
Beyond clinical services, the Eye and Brain Centre aims to strengthen India’s neuro-ophthalmology ecosystem through structured short- and long-term training programmes. It also plans to build strong referral networks involving neurologists, neurosurgeons, and optometrists, enabling a more coordinated approach to patient management.
The initiative builds on a long-standing partnership between LVPEI and D. E. Shaw India focused on expanding access to quality eye care.
Dr. Ramesh Kekunnaya, Head of the Eye and Brain Centre at LVPEI, said, “The Eye and Brain Centre advances LVPEI’s mission of providing excellent and equitable eye care by addressing the critically important and underserved area of eye–brain health.”
Chaitanya Gorrepati, Managing Director and a member of the Operating Committee and Corporate Social Responsibility Committee at D. E. Shaw India, added, “Healthcare is one of our core social responsibility priorities, particularly for marginalized communities across urban and rural India. Through our support for the Eye and Brain Centre, we aim to help broaden access for those with complex and underserved eye–brain conditions. We hope this initiative contributes to building a national resource that integrates patient care, training, and research.”
The centre is expected to deliver over 10,000 patient services annually, including consultations, diagnostics, and follow-up care. It will also contribute to advancing genetic testing and therapy protocols for eye–brain disorders, while conducting symposia and academic engagements to address the knowledge gap in neuro-ophthalmology and build regional capacity.